Trump presidency could prove a salve for pharma merger deals
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/3/2026
- Wall St futures tepid as Middle East tensions keep investors wary
- Broadcom raises AI chip forecast as Big Tech keeps writing bigger checks
- Nvidia to acquire AI platform Hugging Face in landmark $12.9B deal
- Tesla to unveil Cybercab Texas today, details are few
- Snowflake soars 20% on earnings beat and raised guidance
Valeant Pharma (VRX) Sees Solid Upside
November 11, 2016 10:41 AM ESTValeant Pharma (NYSE: VRX) is seeing solid upside Friday. Shares are up 4.4%. Upside comes in part as large shareholder and Director, Bill Ackman, discussed the stock at length yesterday and suggested the company may have to change its name amid all the scrutiny... More
Pfizer (PFE) Receives Positive CHMP Opinion for Change to Nimenrix Marketing Authorization
November 11, 2016 7:44 AM ESTOn 10 November 2016, the Committee for Medicinal Products for Human Use (CHMP) adopted a positive opinion recommending a change to the terms of the marketing authorisation for the medicinal product Nimenrix. The marketing authorisation holder for this medicinal product is Pfizer Limited (NYSE:... More
